These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9724992)

  • 1. False family history of breast cancer in the family cancer clinic.
    Kerr B; Foulkes WD; Cade D; Hadfield L; Hopwood P; Serruya C; Hoare E; Narod SA; Evans DG
    Eur J Surg Oncol; 1998 Aug; 24(4):275-9. PubMed ID: 9724992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic.
    Henriksson K; Olsson H; Kristoffersson U
    Acta Oncol; 2004; 43(7):637-49. PubMed ID: 15545184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic counseling in familial breast cancer].
    Pichert G
    Ther Umsch; 2008 Apr; 65(4):235-41. PubMed ID: 18622917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic.
    Gregory H; Schofield A; de Silva D; Semper J; Milner B; Allan L; Haites N
    J Med Genet; 1996 Mar; 33(3):187-92. PubMed ID: 8728689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast/ovarian cancer--pitfalls in genetic counseling.
    Dagan E; Gershoni-Baruch R
    Clin Genet; 2001 Oct; 60(4):310-3. PubMed ID: 11683778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of extended family history in assessment of risk for breast and colon cancer.
    Solomon BL; Whitman T; Wood ME
    BMC Fam Pract; 2016 Sep; 17(1):126. PubMed ID: 27580697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.
    Lynch HT; Snyder CL; Lynch JF; Riley BD; Rubinstein WS
    J Clin Oncol; 2003 Feb; 21(4):740-53. PubMed ID: 12586815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring family relationships in cancer risk counseling using the genogram.
    Daly M; Farmer J; Harrop-Stein C; Montgomery S; Itzen M; Costalas JW; Rogatko A; Miller S; Balshem A; Gillespie D
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):393-8. PubMed ID: 10207645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic counseling for women with an intermediate family history of breast cancer.
    Burke W; Culver JO; Bowen D; Lowry D; Durfy S; McTiernan A; Andersen MR
    Am J Med Genet; 2000 Feb; 90(5):361-8. PubMed ID: 10706356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counseling, familial breast cancer, and the surgeon's responsibility.
    Lynch HT; Albano WA; Lynch JF
    Plast Reconstr Surg; 1980 Aug; 66(2):303-10. PubMed ID: 7403319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic counselling in the cancer family clinic.
    Murday V
    Eur J Cancer; 1994; 30A(13):2012-5. PubMed ID: 7734215
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA1 gene testing for breast and ovarian cancer in one family.
    Crosbie A; Brewer C; Campbell K; MacKay J
    Br J Nurs; 1998 Dec 10-1999 Jan 13; 7(22):1386-92. PubMed ID: 10076219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.
    Darooei M; Poornima S; Salma BU; Iyer GR; Pujar AN; Annapurna S; Shah A; Maddali S; Hasan Q
    Tumour Biol; 2017 Feb; 39(2):1010428317694303. PubMed ID: 28231738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
    Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
    Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management.
    Marchina E; Fontana MG; Speziani M; Salvi A; Ricca G; Di Lorenzo D; Gervasi M; Caimi L; Barlati S
    Oncol Rep; 2010 Dec; 24(6):1661-7. PubMed ID: 21042765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk assessment for familial occurrence of breast cancer].
    Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
    Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study.
    Hallowell N; Murton F; Statham H; Green JM; Richards MP
    BMJ; 1997 Jan; 314(7076):281-3. PubMed ID: 9022494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.